ENDRA Life Sciences (Nasdaq: NDRA)’s Post

June 13 marks Global Fatty Liver Day, a vital initiative to raise awareness about a disease that affects roughly 2 billion people worldwide. At ENDRA Life Sciences, we're pioneering Thermo Acoustic Enhanced UltraSound (TAEUS®) to assess liver fat non-invasively at 1/40th the cost of an MRI, at the point of patient care. Join us in our mission to broaden access to better healthcare and advance the diagnosis and understanding of steatotic liver disease (SLD). #FattyLiverDay #HealthcareInnovation #ENDRALifeSciences #TAEUS

High-energy 10-minute dive into the metabolic health market and evolving technologies. https://lnkd.in/ekrRK24c Thanks @Robert “Sully” Sullivan and @Mary Burt-Godwin #MASLD #ENDRA #TAEUS #SLD

Had a great discussion on The Wall Street Resource about Steatotic Liver Disease, approaching game-changing therapies, and the need for better diagnostics. Listen here: https://lnkd.in/eFMJYeu #ENDRA #SLD #TAEUS #MASLD

ENDRA's great sales team demonstrating our liver fat measurement technology at the UK Diabetes Professional Care conference. Liver fat is increasingly viewed as a primary biomarker of overall metabolic health. #endra #TAEUS #MASLD #diabetes

ENDRA's TAEUS technology on display at EASD in Hamburg. The excellent traffic we're seeing is a testament to the growing interest in liver health as a metabolic biomarker in endocrinology. #ENDRA #TAEUS #EASD #SLD #MAFLD #liverhealth #endocrinology